13F-HR filed by Darwin Global Management, Ltd.
Darwin Global Management, Ltd. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 4 holding rows worth $160,624,657.
- Accession
- 0001892688-23-000024
- Filer
- CIK 1839209
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 4 entries on the cover page, a total value of $160,624,657 stated on the cover page (in dollars after the unit check, H1), rows summing to $160,624,657 with VALUE read as dollars as filed, 13F file number 028-21006. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 297,701 | $112,778,070 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 428,532 | $20,578,107 | dollars as filed | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 7,584,489 | $17,216,790 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 91,379 | $10,051,690 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892688-23-000024 | this filing | 2023-02-14 | acceptance time not in the bulk data set |